SPA17 and interstitial lung disease: Finally, transcriptomic data from SSc, SSc‐ILD, and IPF patients, combined with single‐cell sequencing of IPF and small‐cohort qPCR from peripheral blood, indicated that SPA17 may play as an pan‐marker in ILD and associate with deterioration of lung function.